Actively Recruiting
Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)
Led by China Medical University Hospital · Updated on 2026-01-26
100
Participants Needed
1
Research Sites
255 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.
CONDITIONS
Official Title
Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- DSM-5 diagnosis of ADHD
- No changes in ADHD treatment (pharmacological or psychological) within 4 weeks before the trial
- SNAP-IV inattention subscale score of 12 or higher, or hyperactivity subscale score of 12 or higher, or combined inattention plus hyperactivity subscale score of 24 or higher
You will not qualify if you...
- IQ less than 80
- Allergy to omega-3 fatty acids
- Physical disorders such as thyroid dysfunction or cancer
- Psychiatric comorbidities including substance use disorder, psychotic disorders, bipolar disorder, or major depressive disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China Medical University Hospital
Taichung, Taiwan, 404
Actively Recruiting
Research Team
P
Pei-Chen Chang, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here